Literature DB >> 2838150

Demonstration of Chromogranin A in human neuroendocrine cell lines by immunohistology and immunoassay.

L J Deftos1, R I Linnoila, D N Carney, D W Burton, S S Leong, D T O'Connor, S S Murray, A F Gazdar.   

Abstract

We have used immunohistology and radioimmunoassay procedures to study Chromogranin A (CgA) in human neuroendocrine tumor cell lines, especially small cell lung cancers (SCLC). By immunohistology, CgA could be detected in 11 of 18 classical SCLC cell lines, in a medullary thyroid carcinoma (MTC) cell line, and in only one of 13 variant- or non-SCLC cell lines. By radioimmunoassay, CgA could be detected in the cells and culture media of all of the classical SCLC cell lines tested. Many of the classical SCLC cell lines also produced calcitonin (CT). These studies demonstrate that CgA production is a common feature of SCLC cell lines, especially those with neuroendocrine characteristics.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2838150     DOI: 10.1002/1097-0142(19880701)62:1<92::aid-cncr2820620117>3.0.co;2-t

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  The neuroendocrine and neural profiles of neuroblastomas, ganglioneuroblastomas, and ganglioneuromas.

Authors:  W M Molenaar; D L Baker; D Pleasure; V M Lee; J Q Trojanowski
Journal:  Am J Pathol       Date:  1990-02       Impact factor: 4.307

2.  A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumours.

Authors:  G P Bernini; A Moretti; M Ferdeghini; S Ricci; C Letizia; E D'Erasmo; G F Argenio; A Salvetti
Journal:  Br J Cancer       Date:  2001-03-02       Impact factor: 7.640

3.  Characterisation of circulating chromogranin A in human cancer patients.

Authors:  A Corti; A Gasparri; F X Chen; M Pelagi; A Brandazza; A Sidoli; A G Siccardi
Journal:  Br J Cancer       Date:  1996-04       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.